{"id":2092,"date":"2024-08-29T13:31:34","date_gmt":"2024-08-29T13:31:34","guid":{"rendered":"https:\/\/das.oasisghana.com\/das\/?page_id=2092"},"modified":"2025-07-07T22:58:58","modified_gmt":"2025-07-07T22:58:58","slug":"investor-relations-2","status":"publish","type":"page","link":"https:\/\/das.oasisghana.com\/das\/investor-relations-2\/","title":{"rendered":"Investor Relations"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Director Responsible for Minority Shareholders<\/span><\/h3><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

<\/span> <\/span><\/h4>
<\/span>\n\t\t\t<\/span><\/div>\t\t\t\t\t

We are pleased to introduce Dr. Barima Afrane as our Minority Shareholder Representative. With his extensive background in pharmacology and a wealth of experience in the pharmaceutical industry, Dr. Afrane embodies our commitment to inclusivity and transparency. His appointment will ensure that the voices of minority shareholders are heard and considered in our corporate governance structure. He will provide a clear and direct channel for feedback, fostering open communication between the board and shareholders. His presence on the board promotes a more inclusive environment, where all shareholders, regardless of their ownership stake, have a voice. Dr. Barima Afrane is a renowned Pharmacologist with a distinguished career as a Lecturer and Medical Advisor in the United States and the Middle East. He brings a wealth of academic and practical experience to our board.<\/p>

For any questions, concerns, or feedback, minority shareholders may reach Dr. Barima Afrane via email on: barima.afrane@dasplcgh.com<\/a><\/p><\/div><\/div><\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Director Responsible for Investor Relations<\/span><\/h3><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

<\/span> <\/span><\/h4>
<\/span>\n\t\t\t<\/span><\/div>\t\t\t\t\t
Mr. Kwasi Yirenkyi, has been nominated by the board as a Director Responsible for Investor Relations having served as Managing Director of Starwin Products Limited between November 2007 and July 2015. Prior to that, he was a Non-Executive Director of the Company between March 2005 and November 2007.<\/div>
Mr. Yirenkyi has a wealth of experience in General Management and became the Chief Corporate Affairs Officer of Dannex Ayrton Starwin Plc when the Company was formed in 2019. Kwasi was a Senior Corporate Manager with Merchant Bank Ghana Limited, now Universal Merchant Bank for eight years. He was responsible for managing portfolios in the Public Sector, among other areas in the bank. He has had further employment with Deloitte and Touche Consulting West Africa, as a Management Consultant.<\/div>
In this role Mr. Kwasi Yirenkyi will be responsible for dealing with investor relations with the exception of Minority Shareholders.<\/div><\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Director Responsible for Minority Shareholders We are pleased to introduce Dr. Barima Afrane as our Minority Shareholder Representative. With his extensive background in pharmacology and a wealth of experience in the pharmaceutical industry, Dr. Afrane embodies our commitment to inclusivity and transparency. His appointment will ensure that the voices of minority shareholders are heard and…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"tpgb_global_settings":"","footnotes":""},"class_list":["post-2092","page","type-page","status-publish","hentry"],"acf":[],"tpgb_featured_images":null,"tpgb_post_meta_info":{"get_date":"August 29, 2024","author_name":"DasPharma","author_url":"https:\/\/das.oasisghana.com\/das\/author\/daspharma\/","author_email":"jshaibu@gmail.com","author_website":"https:\/\/das.oasisghana.com\/das","author_description":"","author_facebook":"","author_twitter":"","author_instagram":"","author_role":["administrator"],"author_firstname":"","author_lastname":"","user_login":"DasPharma","author_avatar":"","author_avatar_url":"https:\/\/secure.gravatar.com\/avatar\/e96a1350a3e5b8f1f692d3e6f7b4f56a?s=96&d=mm&r=g","comment_count":0,"post_likes":0,"post_views":0},"tpgb_post_category":[],"_links":{"self":[{"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/pages\/2092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/comments?post=2092"}],"version-history":[{"count":35,"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/pages\/2092\/revisions"}],"predecessor-version":[{"id":2463,"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/pages\/2092\/revisions\/2463"}],"wp:attachment":[{"href":"https:\/\/das.oasisghana.com\/das\/wp-json\/wp\/v2\/media?parent=2092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}